131 Loss of PD-L1 Expression in Metastatic Merkel Cell Carcinoma Strongly Correlates With a Poor Prognosis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2018English

TLR4 Expression Correlated With PD-L1 Expression Indicates a Poor Prognosis in Patients With Peripheral T-Cell Lymphomas

Cancer Management and Research
Oncology
2019English

Expression of Lactate Dehydrogenase C Correlates With Poor Prognosis in Renal Cell Carcinoma

Tumor Biology
MedicineCancer Research
2017English

Upregulation of Circulating PD-L1/PD-1 Is Associated With Poor Post-Cryoablation Prognosis in Patients With HBV-Related Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2011English

PD-L1 Expression Is Associated With FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis

Journal of Cancer
Oncology
2017English

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Upregulation of NETO2 Expression Correlates With Tumor Progression and Poor Prognosis in Colorectal Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Aberrant Expression of Beclin-1 and LC3 Correlates With Poor Prognosis of Human Hypopharyngeal Squamous Cell Carcinoma

PLoS ONE
Multidisciplinary
2013English

Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated With PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy

Frontiers in Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy